Biology and validation of PCSK9 as a novel target to lower LDL-C
Prof. John JP Kastelein
The programme was CME accredited by EBAC
Lecture by Prof. John Kastelein, Amsterdam, The Netherlands, held during EBAC accredited symposium 'Managing Innovations in lipid management: Evolving insights and implications from PCSK9 research' held during ESC2014 in Barcelona
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.